Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Anan Yin"'
Autor:
Yufeng Wang, Xiaoyue Chu, Xihui Chen, Anan Yin, Yan Yao, Li Wang, Hua Xu, Fangfang Liu, Kun Chen, Yuanming Wu
Publikováno v:
Therapeutic Advances in Hematology, Vol 14 (2023)
Background: Some blood groups, such as S and s blood groups in the MNS blood group system, and Kidd and CTL2 blood group systems, can cause severe fetal and newborn alloimmune disorders. Non-invasive prenatal testing (NIPT) to predict fetal blood gro
Externí odkaz:
https://doaj.org/article/940109aa5825458797b4d47a4ac670f3
Autor:
Xihui Chen, Fangfang Liu, Bowen Li, Yufeng Wang, Lijuan Yuan, Anan Yin, Qi Chen, Weihong Hu, Yan Yao, Mengjie Zhang, YuanMing Wu, Kun Chen
Publikováno v:
Cell & Bioscience, Vol 12, Iss 1, Pp 1-23 (2022)
Abstract Background Neurodegenerative diseases encompass an extensive and heterogeneous group of nervous system disorders which are characterized by progressive degeneration and death of neurons. Many lines of evidence suggest the participation of mi
Externí odkaz:
https://doaj.org/article/51c3d9c94a0248839c8125c26a8b7fd9
Autor:
Anan Yin, Zhende Shang, Amandine Etcheverry, Yalong He, Marc Aubry, Nan Lu, Yuhe Liu, Jean Mosser, Wei Lin, Xiang Zhang, Yu Dong
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
The clinical and molecular implications of DNA methylation alterations remain unclear among the majority of glioblastomas (GBMs) without glioma-CpGs island methylator phenotype (G-CIMP); integrative multi-level molecular profiling may provide useful
Externí odkaz:
https://doaj.org/article/8800ac7fe4a64794b02ac89cba1fa96a
Autor:
Juan Li, Haifeng Tang, Yun Zhang, Chi Tang, Bo Li, Yuangang Wang, Zhenhui Gao, Peng Luo, Anan Yin, Xiaoyang Wang, Guang Cheng, Zhou Fei
Publikováno v:
PLoS ONE, Vol 9, Iss 1 (2014)
Externí odkaz:
https://doaj.org/article/315fc09b269c46c4a2a2261b2b99763d
Autor:
Juan Li, Haifeng Tang, Yun Zhang, Chi Tang, Bo Li, Yuangang Wang, Zhenhui Gao, Peng Luo, Anan Yin, Xiaoyang Wang, Guang Cheng, Zhou Fei
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81258 (2013)
Saponin 1 is a triterpeniod saponin extracted from Anemone taipaiensis, a traditional Chinese medicine against rheumatism and phlebitis. It has also been shown to exhibit significant anti-tumor activity against human leukemia (HL-60 cells) and human
Externí odkaz:
https://doaj.org/article/360bfc0babcd48bf8c9603898a4968b7
Autor:
Jiu Wang, Meng Zhang, Yi-feng Liu, Yan Yao, Yu-sha Ji, Amandine Etcheverry, Kun Chen, Bao-qiang Song, Wei Lin, Anan Yin, Ya-long He
Publikováno v:
Epigenomics
Epigenomics, 2022, 14 (20), pp.1233-1247. ⟨10.2217/epi-2022-0344⟩
Epigenomics, 2022, 14 (20), pp.1233-1247. ⟨10.2217/epi-2022-0344⟩
Aim: We aimed to identify potent CpG signatures predicting temozolomide (TMZ) response in glioblastomas (GBMs) that do not have the glioma-CpG island methylator phenotype (G-CIMP) but have a methylated promoter of MGMT (me MGMT). Materials & methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708af101512f1f4d877b9d10530ee45f
https://hal.science/hal-03898822
https://hal.science/hal-03898822
Autor:
Xihui Chen, Fangfang Liu, Kun Chen, Yufeng Wang, Anan Yin, Xiaowei Kang, Shanming Yang, Hanwen Zhao, Songqi Dong, Yunqing Li, Jing Chen, Yuanming Wu
Publikováno v:
CNS neurosciencetherapeutics. 28(12)
TFG-related axonal Charcot-Marie-Tooth (CMT) disease is a late-onset, autosomal dominant, hereditary motor, and sensory neuropathy characterized by slowly progressive weakness and atrophy of the distal muscles. The objective of this study was to dete
A Novel Pseudogene Methylation Signature to Predict Temozolomide Outcome in Non-G-CIMP Glioblastomas
Autor:
Bowen Li, Jiu Wang, Fangfang Liu, Rui Li, Weihong Hu, Amandine Etcheverry, Marc Aubry, Jean Mosser, Anan Yin, Xiang Zhang, Yuanming Wu, Kun Chen, Yalong He, Li Wang
Publikováno v:
Journal of Oncology
Journal of Oncology, 2022, 2022, pp.6345160. ⟨10.1155/2022/6345160⟩
Journal of Oncology, 2022, 2022, pp.6345160. ⟨10.1155/2022/6345160⟩
International audience; Objective. Alterations in the methylation state of pseudogenes may serve as clinically useful biomarkers of glioblastomas (GBMs) that do not have glioma-CpG island methylator phenotype (G-CIMP).Methods. Non-G-CIMP GBM datasets
Autor:
Marc Aubry, Jean Mosser, Bowen Li, Fangfang Liu, Weihong Hu, Yalong He, Xiang Zhang, Yuanming Wu, Rui Li, Anan Yin, Amandine Etcheverry, Kun Chen
Background Dysregulation and dysfunction of DNA damage response (DDR) have prognostic and predictive implications for glioblastomas (GBMs) without glioma-CpGs island methylator phenotype (G-CIMP); mathematical modeling based on DNA methylation abnorm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59d5be7dc65a0ed978402ab311fafb65
https://doi.org/10.21203/rs.3.rs-823543/v1
https://doi.org/10.21203/rs.3.rs-823543/v1
Autor:
Jill S. Barnholtz-Sloan, Anan Yin, Amandine Etcheverry, Wei Zhang, Marc Aubry, Xiang Zhang, Jean Mosser, Wei-jun Chen, Yalong He, En-ming Kang
Publikováno v:
CNS Neuroscience and Therapeutics
CNS Neuroscience and Therapeutics, Wiley, 2019, 25 (9), pp.937-950. ⟨10.1111/cns.13133⟩
CNS Neuroscience and Therapeutics, 2019, 25 (9), pp.937-950. ⟨10.1111/cns.13133⟩
CNS Neuroscience & Therapeutics
CNS Neuroscience and Therapeutics, Wiley, 2019, 25 (9), pp.937-950. ⟨10.1111/cns.13133⟩
CNS Neuroscience and Therapeutics, 2019, 25 (9), pp.937-950. ⟨10.1111/cns.13133⟩
CNS Neuroscience & Therapeutics
International audience; Aims: DNA methylation has been found to regulate microRNAs (miRNAs) expression, but the prognostic value of miRNA-related DNA methylation aberration remained largely elusive in cancers including glioblastomas (GBMs). This stud